Upregulated levels of human β-defensins in patients with seasonal allergic rhinitis after allergen-specific immunotherapy treatment

International Forum of Allergy and Rhinology

Volumn 3, Issue 2, 2013, Pages 99-103

  Bogefors, Jesper ^a   Kvarnhammar, Anne Månsson ^b   Cardell, Lars Olaf ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Allergic rhinitis; Allergy immunotherapy; Rhinitis; Skin prick test; Subcutaneous immunotherapy

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; MESSENGER RNA;

ADOLESCENT; ADULT; ALLERGEN SPECIFIC IMMUNOTHERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAY FEVER; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INNATE IMMUNITY; MALE; NASAL BIOPSY; NASAL LAVAGE; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADOLESCENT; ADULT; BETA-DEFENSINS; CASE-CONTROL STUDIES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL LAVAGE FLUID; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS, ALLERGIC, SEASONAL; RNA, MESSENGER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84873935693     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21127     Document Type: Article

References (28)

1. Schwaab M, Gurr A, Hansen S, et al. Human beta-defensins in different states of diseases of the tonsilla palatina. Eur Arch Otorhinolaryngol. 2010;267:821-830.
2. Zuyderduyn S, Ninaber DK, Schrumpf JA, et al. IL-4 and IL-13 exposure during mucociliary differentiation of bronchial epithelial cells increases antimicrobial activity and expression of antimicrobial peptides. Respir Res. 2011;12:59.
3. Pasupuleti M, Schmidtchen A, Malmsten M. Antimicrobial peptides: Key components of the innate immune system. Crit Rev Biotechnol. 2012;32:143-171.
4. Wiesner J, Vilcinskas A. Antimicrobial peptides: the ancient arm of the human immune system. Virulence. 2010;1:440-464.
5. Laudien M, Dressel S, Harder J, Glaser R. Differential expression pattern of antimicrobial peptides in nasal mucosa and secretion. Rhinology. 2011;49:107-111.
6. Wollenberg A, Rawer HC, Schauber J. Innate immunity in atopic dermatitis. Clin Rev Allergy Immunol. 2011;41:272-281.
7. Bryborn M, Mansson A, Cardell LO, Adner M. Differentiated S100A7 expression in infected tonsils and tonsils from allergic individuals. FEMS Immunol Med Microbiol. 2008;53:413-420.
8. Nomura I, Goleva E, Howell MD, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol. 2003;171:3262-3269.
9. Shamji MH, Durham SR. Mechanisms of immunotherapy to aeroallergens. Clin Exp Allergy. 2011;41:1235-1246.
10. Purello-D'Ambrosio F, Gangemi S, Merendino RA, et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy. 2001;31:1295-1302.
11. Bryborn M, Adner M, Cardell LO. Psoriasin, one of several new proteins identified in nasal lavage fluid from allergic and non-allergic individuals using 2-dimensional gel electrophoresis and mass spectrometry. Respir Res. 2005;6:118.
12. Bogefors J, Rydberg C, Uddman R, et al. Nod1, nod2 and nalp3 receptors, new potential targets in treatment of allergic rhinitis? Allergy. 2010;65:1222-1226.
13. Mansson A, Bogefors J, Cervin A, Uddman R, Cardell LO. Nod-like receptors in the human upper airways: A potential role in nasal polyposis. Allergy. 2011;66:621-628.
14. Guani-Guerra E, Negrete-Garcia MC, Montes-Vizuet R, Asbun-Bojalil J, Teran LM. Human beta-defensin-2 induction in nasal mucosa after administration of bacterial lysates. Arch Med Res. 2011;42:189-194.
15. Hui Y, Wohlers J, Podschun R, et al. Antimicrobial peptides in nasal secretion and mucosa with respect to S. aureus colonisation in Wegener s granulomatosis. Clin Exp Rheumatol. 2011;29:S49-S56.
16. Claeys S, de Belder T, Holtappels G, et al. Human beta-defensins and toll-like receptors in the upper airway. Allergy. 2003;58:748-753.
17. Proud D, Sanders SP, Wiehler S. Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo. J Immunol. 2004;172:4637-4645.
18. Harder J, Meyer-Hoffert U, Teran LM, et al. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol. 2000;22:714-721.
19. Zanger P, Nurjadi D, Vath B, Kremsner PG. Persistent nasal carriage of staphylococcus aureus is associated with deficient induction of human beta-defensin 3 after sterile wounding of healthy skin in vivo. Infect Immun. 2011;79:2658-2662.
20. Tieu DD, Peters AT, Carter RG, et al. Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis. J Allergy Clin Immunol. 2010;125:667-675.
21. Kvarnhammar AM, Rydberg C, Jarnkrants M, et al. Diminished levels of nasal S100A7 (psoriasin) in seasonal allergic rhinitis: an effect mediated by Th2 cytokines. Respir Res. 2012;13:2.
22. Vanhinsbergh LJ, Powe DG, Jones NS. Reduction of tlr2 gene expression in allergic and nonallergic rhinitis. Ann Allergy Asthma Immunol. 2007;99:509-516.
23. Bogefors J, Kvarnhammar A, Höckerfelt U, Cardell LO. Reduced tonsillar expression of human β-defensin 1, 2 and 3 in allergic rhinitis. FEMS Immunol Med Microbiol. 2012;65:431-438.
24. Howell MD. The role of human beta defensins and cathelicidins in atopic dermatitis. Curr Opin Allergy Clin Immunol. 2007;7:413-417.
25. Beisswenger C, Kandler K, Hess C, et al. Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol. 2006;177:1833-1837.
26. Howell MD, Boguniewicz M, Pastore S, et al. Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol. 2006;121:332-338.
27. Kisich KO, Carspecken CW, Fieve S, Boguniewicz M, Leung DY. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol. 2008;122:62-68.
28. Ciprandi G, Tosca MA, Marseglia GL. Sublingual immunotherapy mechanisms of action: the role of Th1 response. Int J Immunopathol Pharmacol. 2009;22:9-12.